Day: November 8, 2021

Total Energy Services Inc. Announces Q3 2021 Results

Total Energy Services Inc. Announces Q3 2021 Results

CALGARY, Alberta, Nov. 08, 2021 (GLOBE NEWSWIRE) — Total Energy Services Inc. (“Total Energy” or the “Company”) (TSX:TOT) announces its consolidated financial results for the three and nine months ended September 30, 2021. Financial Highlights ($000’s except per share data)   Three months ended September 30   Nine months ended September 30    2021  2020 Change    2021  2020 Change Revenue $ 118,881   $ 77,240   54 %   $ 296,947   $ 282,278   5 % Operating income (loss)   6,415     (5,894 ) nm       (3,093 )   (32,526 ) (90 %) EBITDA (1)   27,015     17,869   51 %     63,448     61,658   3 % Cashflow   26,253     19,810   33 %     58,047     55,514   5 % Net income (loss)   4,279     (4,602 ) nm       (1,464 )   (28,723 ) (95 %) Attributable to shareholders   4,278     (4,618 ) nm       (1,409 )   (28,711 ) (95 %)                             Per...

Continue reading

Westport Fuel Systems Reports Third Quarter 2021 Financial Results

Westport Fuel Systems Reports Third Quarter 2021 Financial Results

VANCOUVER, British Columbia, Nov. 08, 2021 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“WFS“) (TSX:WPRT / Nasdaq:WPRT) reported financial results for the third quarter ended September 30, 2021, and provided an update on operations. All figures are in U.S. dollars unless otherwise stated. THIRD QUARTER 2021 HIGHLIGHTS Revenues of $74.3 million, up 14% compared to the same period in 2020, due to the continued recovery of sales volumes in our light-duty OEM businesses since the beginning of the COVID-19 pandemic and $7.1 million revenue from our recently acquired fuel storage business, partially offset by the decrease in the independent aftermarket (“IAM”) business Net loss of $5.8 million and net loss per share of $0.03 mainly due to increased operating expenses, lower government wage-subsidy and support...

Continue reading

KnowBe4 Announces Launch of Proposed Follow-On Offering by Selling Stockholders

KnowBe4 Announces Launch of Proposed Follow-On Offering by Selling Stockholders

TAMPA BAY, Fla., Nov. 08, 2021 (GLOBE NEWSWIRE) — KnowBe4, Inc. (NASDAQ: KNBE), provider of the leading security awareness training and simulated phishing platform, today announced that it has commenced a follow-on public offering of its Class A common stock pursuant to a registration statement on Form S-1 filed previously with the U.S. Securities and Exchange Commission (the “SEC”). Certain existing stockholders of KnowBe4 are offering 7,000,000 shares of Class A common stock. In addition, the underwriters of the offering will have a 30-day option to purchase up to an additional 1,050,000 shares of Class A common stock from the selling stockholders. KnowBe4 will not receive any proceeds from the sale of the shares by the selling stockholders. Morgan Stanley, Goldman Sachs & Co. LLC, BofA Securities and KKR Capital Markets,...

Continue reading

TPI Composites, Inc. Announces Third Quarter 2021 Earnings Results – Added New Lines in China for Vestas and Secures Strategic Investment from Oaktree Capital Management of up to $600 Million

TPI Composites, Inc. Announces Third Quarter 2021 Earnings Results – Added New Lines in China for Vestas and Secures Strategic Investment from Oaktree Capital Management of up to $600 Million

SCOTTSDALE, Ariz., Nov. 08, 2021 (GLOBE NEWSWIRE) — TPI Composites, Inc. (Nasdaq: TPIC), the only independent manufacturer of composite wind blades with a global footprint, today reported financial results for the third quarter ended September 30, 2021. Highlights For the quarter ended September 30, 2021: Net sales of $479.6 million Net loss of $30.7 million or ($0.83) per diluted share EBITDA loss of $6.5 million Adjusted EBITDA of $0.2 million KPIs   3Q’21 3Q’20     Sets¹ 830 1,037     Estimated megawatts² 3,395 3,571     Utilization3 76% 93%     Dedicated manufacturing lines4 54 55     Manufacturing lines installed5 54 54   Number of wind blade sets (which consist of three wind blades) produced worldwide during the period. Estimated megawatts of energy capacity to be generated by wind blade sets produced during...

Continue reading

TPI Composites, Inc. Announces up to $600 Million Capital Investment from Oaktree – Strengthens Liquidity Position and Supports Long Term Strategy and Prospects

TPI Composites, Inc. Announces up to $600 Million Capital Investment from Oaktree – Strengthens Liquidity Position and Supports Long Term Strategy and Prospects

SCOTTSDALE, Arizona, Nov. 08, 2021 (GLOBE NEWSWIRE) — TPI Composites, Inc. (Nasdaq: TPIC), the only independent manufacturer of composite wind blades with a global footprint, announced today that it has entered into a stock purchase agreement to issue and sell $400 million of Series A Preferred Stock to investment funds managed by Oaktree Capital Management (“Oaktree”). Under the terms of the stock purchase agreement, TPI will issue and sell $350 million of Series A Preferred Stock to Oaktree, subject to customary closing conditions. TPI also may elect at its option to require Oaktree to purchase an additional $50 million of Series A Preferred Stock upon the same terms and conditions as the initial issuance of the Series A Preferred Stock during the two-year period following the closing of the initial issuance. TPI expects that...

Continue reading

Day One Reports Third Quarter 2021 Financial Results and Corporate Progress

Day One Reports Third Quarter 2021 Financial Results and Corporate Progress

Enrollment Progresses in the Pivotal Phase 2 FIREFLY-1 Clinical Trial of DAY101 in Patients with pLGG; Initial Data Expected in 1H 2022 Upcoming CTOS Meeting to Highlight Single Agent Activity of Lead Drug Candidate, DAY101, in Spindle Cell Carcinoma Compassionate Use Case SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genomically defined cancers, today announced financial results for the third quarter of 2021 and highlighted recent corporate achievements. “We continue to build momentum in our lead program with the granting of Rare Pediatric Disease Designation for DAY101 for the treatment of pediatric low-grade glioma during the third quarter,”...

Continue reading

First Advantage Announces Secondary Offering of Common Stock

First Advantage Announces Secondary Offering of Common Stock

ATLANTA, Nov. 08, 2021 (GLOBE NEWSWIRE) — First Advantage Corporation (“First Advantage”) (NASDAQ: FA), a leading global provider of technology solutions for screening, verifications, safety and compliance related to human capital, today announced that certain of its stockholders (the “Selling Stockholders”), including affiliates of Silver Lake Group, L.L.C., intend to offer for sale in an underwritten secondary offering 15,000,000 shares of common stock of First Advantage pursuant to a registration statement filed by First Advantage with the U.S. Securities and Exchange Commission (the “SEC”). The Selling Stockholders expect to grant the underwriters in the offering a 30-day option to purchase up to an additional 2,250,000 shares of common stock. No shares are being sold by First Advantage. The Selling Stockholders will receive...

Continue reading

Viemed Healthcare Announces Principal Physician Researcher to Present Latest Clinical Findings

Viemed Healthcare Announces Principal Physician Researcher to Present Latest Clinical Findings

LAFAYETTE, La., Nov. 08, 2021 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD and TSX: VMD.TO), a home medical equipment supplier and the nation’s largest independent provider of ventilation that provides post-acute respiratory care services, announced today that the Company’s Chief Medical Officer, Dr. William Frazier, ABIM Board Certified in Internal, Pulmonary, Critical Care, and Sleep Disorders Medicine and leader of two peer reviewed clinical studies (the “recent studies”) concerning the benefits of Non-Invasive Ventilation at Home (NIVH) therapy in COPD-CRF patients, will be sharing his professional insights and perspective during a free public Webinar on December 9 at 12:00 p.m. EST. WEBINAR DETAILS EVENT:   Learn how non-invasive ventilation at home treatment has proven to reduce healthcare...

Continue reading

Roivant to Report Financial Results for the Quarter Ended September 30, 2021 on Monday, November 15, 2021

Roivant to Report Financial Results for the Quarter Ended September 30, 2021 on Monday, November 15, 2021

Quarterly investor call and webcast scheduled on Monday, November 15th at 8:00am ET Roivant will also present at the Jefferies London Healthcare and Evercore ISI HealthCONx investor conferences in November BASEL, Switzerland, LONDON, NEW YORK and BOSTON, Nov. 08, 2021 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq: ROIV), a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 15, 2021 to report its second quarter 2021 financial results and provide a corporate update. To access the live conference call, please dial +1-844-224-1923 (domestic) or +1-214-989-7105 (international) and use conference ID 3545615. A webcast of the call will also be available under “Events & Presentations” in the...

Continue reading

Kronos Bio and Tempus Announce Multi-Year Collaboration to Provide Kronos Bio With Access to Tempus’ Platform

Kronos Bio and Tempus Announce Multi-Year Collaboration to Provide Kronos Bio With Access to Tempus’ Platform

Kronos to receive broad access to Tempus’ real-world data and proprietary tools and materials to expand preclinical hypotheses testing capabilities and inform more streamlined clinical trial design Agreement builds on earlier collaboration between companies announced in February 2021 SAN MATEO, Calif. and CAMBRIDGE, Mass. and CHICAGO, Nov. 08, 2021 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, and Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year collaboration that provides Kronos Bio with access to Tempus’ real-world genomic and transcriptomic data and data analytics tools. Under the agreement, Kronos Bio will have access to a number of precision medicine tools, including Tempus’ modeling lab, which houses...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.